Karen Sterling
Stock Analyst at Westpark Capital
(2.17)
# 3,172
Out of 5,036 analysts
5
Total ratings
33.3%
Success rate
18.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Karen Sterling
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TTRX Turn Therapeutics | Downgraded: Sell | $6.15 → $10 | $12.10 | -17.36% | 2 | Sep 14, 2026 | |
| REGN Regeneron Pharmaceuticals | Initiated Coverage: Hold | n/a | $742.12 | n/a | 1 | Sep 15, 2023 | |
| NRXS NeurAxis | Initiated Coverage: Buy | $7.5 | $6.83 | n/a | 1 | Aug 23, 2023 | |
| VRTX Vertex Pharmaceuticals | Initiated Coverage: Hold | n/a | $505.64 | n/a | 1 | May 25, 2023 |
Turn Therapeutics
Sep 14, 2026
Downgraded: Sell
Price Target: $6.15 → $10
Current: $12.10
Upside: -17.36%
Regeneron Pharmaceuticals
Sep 15, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $742.12
Upside: n/a
NeurAxis
Aug 23, 2023
Initiated Coverage: Buy
Price Target: $7.5
Current: $6.83
Upside: n/a
Vertex Pharmaceuticals
May 25, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $505.64
Upside: n/a